Prof Christian Wolfrum

Prof Christian Wolfrum is the Vice President for Research and a professor in the Department of Health Sciences and Technology (D-HEST) at ETH Zurich. His research group’s main interest is in understanding molecular mechanisms regulating adipocyte formation and activity. The lab uses a translational approach from mice to men in order to elucidate the molecular mechanisms that are the underlying cause of altered adipocyte formation and activity in different models of obesity-associated metabolic disorders, with a special emphasis on the analysis of gene expression, post-translational modifications and lipid species in mouse models and human patients.

Within the context of the BRCCH, Prof Wolfrum sits on the BRCCH Board. He is also a collaborator in the consortium "Precision Microbiota Engineering for Child Health."

Prof Torsten Schwede

Prof Torsten Schwede is a professor of structural bioinformatics at the Biozentrum of the University of Basel and a group leader at the Swiss Institute of Bioinformatics (SIB). Since 2018, he has served as Vice-President for Research and is responsible for career advancement, technology transfer (Unitectra), national and international cooperation, the Grants Office, digital research infrastructures (sciCORE Center for Scientific Computing, CeDA Center for Data Analytics), research networks and open science.

Prof Schwede studied chemistry at the University of Bayreuth and the University of Freiburg. After completing his doctorate in structural biology (protein crystallography), he conducted research at the global pharmaceutical company GlaxoSmithKline in Geneva. In 2001, he joined the University of Basel, where he leads a research group at the Biozentrum on structural bioinformatics with a focus on protein structure prediction. Within the Swiss Personalized Health Network Initiative (SPHN), he was involved in the development of a national health data infrastructure in Switzerland. Starting January 2025, Prof Schwede will be the new President of the SNSF Research Council.

Within the context of the BRCCH, Prof Schwede sits on the Board.

Prof Urs Frey

Prof Urs Frey is the Medical Director and Chair of Paediatrics at University Children’s Hospital Basel (UKBB). He is also the Chairman of the National Steering Board for the Swiss Personalized Health Network. He obtained his medical degree from the University of Bern and a PhD in medical physics from the University of Leicester, UK, with subsequent specialisations in paediatrics and child and youth medicine and pulmonology. Most recently, before joining UKBB, Prof Frey was the Head of Department and Professor of Paediatric Pulmonology at the University Hospital of Bern.

His research interests include lung physiology, the epidemiology of lung growth and development, computational biology and mathematical modelling of complex diseases, with a particular focus on bronchial asthma and chronic lung disease of infancy, as well as other wheezing disorders in infants and preschool children.

Within the context of the BRCCH, Prof Frey sits on the BRCCH Board. He is also is a collaborator in the consortium "Alex".

Prof Sven Panke

Prof Sven Panke is a professor of bioprocess engineering. After his PhD at ETH Zurich, he worked for two years in the biocatalysis group of the chemical company DSM (Geleen, The Netherlands). He returned to ETH in 2001 as an assistant professor and moved in 2008 to the newly founded Department of Biosystems Science and Engineering at ETH Zurich in Basel. His main research topics include biocatalyst engineering, high-throughput screening and synthetic biology. He is currently the Head of the Department of Biosystems Science and Engineering at ETH Zurich.

Prof Primo Schär

Prof Primo Schär is Dean of the Medical Faculty and a professor in the Department of Biomedicine at the University of Basel. He obtained his PhD from the University of Bern and did his postdoctoral work at both the University of Bern and the Imperial Cancer Research Fund (now Cancer Research UK). Prior to joining the University of Basel, Prof Schär was a research group leader at the Institute of Molecular Cancer Research at the University of Zürich.

Prof Schär’s group investigates biological processes that modulate genome plasticity; i.e., the stability of the genetic and epigenetic codes of cell identity. Their objective is to provide a thorough understanding of the molecular mechanisms involved and the consequences of their dysfunction for cell fate, transformation and cancer.

Prof Bill Taylor

Prof William (Bill) Taylor was appointed to the position of Professor of Movement Biomechanics within the Department of Health Sciences and Technology at ETH Zürich in 2012. After achieving his degree in Mechanical Engineering, he completed his Ph.D. in Biomedical Engineering at the University of Bath, England in 1999 using finite element analysis to analyse the bone adaptation that occurs around hip prostheses. After spending a year at the Biomechanics Research Lab, Prince of Wales Hospital, Sydney, Australia, he moved to Germany in 2001, where he led the research group “Functional Analysis” at the Julius Wolff Institute, Charité – Universitätsmedizin Berlin.

As head of the Laboratory for Movement Biomechanics at ETH Zürich, his research now aims to provide new approaches for quantifying functional outcome in patients, both pre-operatively and after therapy. Through developing medical engineering concepts for evaluating joint stability and stiffness, as well as accurate and robust techniques for assessing motion patterns, his goal is to identify musculoskeletal deficits and movement pathologies at an early time point. Using these techniques to evaluate the differences between physiology and pathology, as well as functional status after therapy, his research further aims to complement clinical decision making by opening perspectives for targeting therapies towards patients who would gain most benefit. This research has led to a number of international awards and its impact has also been reflected in over 220 internationally peer-reviewed journal contributions.